生物反馈治疗直肠癌低位前切除综合征疗效观察  

Biofeedback Therapy in the Treatment of Low-anterior Resection Syndrome of Rectal Carcinoma：Effect Obser- vation

作　　者：陈洪亮[1] 王奇[1] 章利[1] 蒋华锋[1] 应晓江[1] 

机构地区：[1]浙江省绍兴市人民医院肛肠外科,浙江绍兴312000

出　　处：《中国肛肠病杂志》2016年第6期10-12,共3页Chinese Journal of Coloproctology

摘　　要：为了观察生物反馈疗法对直肠癌术后低位前切除综合征（LARS）的临床疗效，对2015年3月至2016年1月·我院20例直肠癌低位前切除术后出现LARS的患者进行生物反馈治疗，并检测其肛管静息压、最大收缩压、每天排便次数和排便自控情况。结果显示，治疗后患者肛管静息压、最大收缩压均明显提高[（33．15±1．46）mmHgvs（39．70±1．95）mmHg，（60．05±3．52）mmHgvs（68．70±1．84）mmHg，P〈0．01]，每日排便次数明显减少[（13．25±2．12）次／dVS（4．65±1．18）次／d，P〈0．01]，大便自控的能力也得到了提升。结果表明，生物反馈治疗直肠癌LARS疗效确切。In order to explore the clinical effect of biofeedback therapy in the treatment of low-anterior re- section syndrome of rectal carcinoma（LARS） ,authors gave biofeedback therapy to 20 patients who had re- ceived low-anterior resection of rectal carcinoma and were complicated with LARS from March 2015 to Jan. 2016 yr.,and measure their anal rest pressure（ARP）,max systolic pressure of anus（MSPA）, defecation frequency（times/d）,and self-control status of defecation.As results,after treatment patient＇s ARP and MS-PA were significantly increased[（33.15±1.46） mmHg vs （39.70±1.95） mmHg, （60.05±3.52） mmHg vs （68.70±1.84） mmHg, P〈0.01] ,defecation frequency were significantly decrease [（13.25±2.12） times/d vs （4.65± 1.18） times/d, P 〈0.01 ], as well self-control ablity for defecation also uplifted. Results show that biofeedback therapy for LARS has determined effect.

关 键 词：低位直肠癌 低位前切除术 生物反馈疗法 

分 类 号：R574.62[医药卫生—消化系统]